Report

Embryonic Folate Metabolism and Mouse Neural Tube Defects

Science  26 Jun 1998:
Vol. 280, Issue 5372, pp. 2107-2109
DOI: 10.1126/science.280.5372.2107

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

Folic acid prevents 70 percent of human neural tube defects (NTDs) but its mode of action is unclear. The deoxyuridine suppression test detects disturbance of folate metabolism in homozygoussplotch (Pax3) mouse embryos that are developing NTDs in vitro. Excessive incorporation of [3H]thymidine in splotch embryos indicates a metabolic deficiency in the supply of folate for the biosynthesis of pyrimidine. Exogenous folic acid and thymidine both correct the biosynthetic defect and prevent some NTDs in splotch homozygotes, whereas methionine has an exacerbating effect. These data support a direct normalization of neurulation by folic acid in humans and suggest a metabolic basis for folate action.

  • * To whom correspondence should be addressed. E-mail: a.copp{at}ich.ucl.ac.uk

View Full Text

Related Content